This document serves as the introduction to Chapter VIII of an Ackrell Capital report, presenting their 2018 list of the top 100 private cannabis companies. The text outlines the subjective selection criteria, highlights the financial risks and challenges faced by early-stage cannabis companies, and includes a disclaimer regarding potential conflicts of interest due to Ackrell Capital's investment activities.
| Name | Type | Context |
|---|---|---|
| Ackrell Capital | ||
| Ackrell Capital, LLC | ||
| FINRA | ||
| SIPC |
| Location | Context |
|---|---|
"In this chapter, we present our current list of the Top 100 Private Cannabis Companies."Source
"Most companies on our list are in early stages of development, and many will need to raise capital to succeed."Source
"Readers should be aware that we may have a conflict of interest that could affect the objectivity of our decision to include a company in the list."Source
Complete text extracted from the document (1,776 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document